Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shunqi Tongxie Granules for diarrhea-predominant IBS (liver–spleen disharmony)
CTR20140295Phase 3Completed
- Sponsor
- Xi'an Shangyikang Pharmaceutical Research Institute
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Shunqi Tongxie Granules in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Xi'an Shangyikang Pharmaceutical Research Institute. Started Jul 2014; status: completed.
02
Drugs
Shunqi Tongxie Granules
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20140295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140295.